This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Jul;5(7):1639-40.

doi: 10.1158/1535-7163.MCT-06-C02.

Liposomal delivery as a mechanism to enhance synergism between anticancer drugs

Affiliations

PMID: 16891448
DOI: 10.1158/1535-7163.MCT-06-C02

Comment

Liposomal delivery as a mechanism to enhance synergism between anticancer drugs

Robert J Lee. Mol Cancer Ther. 2006 Jul.

. 2006 Jul;5(7):1639-40.

doi: 10.1158/1535-7163.MCT-06-C02.

Author

Affiliation

¹ College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210, USA. lee.1339@osu.edu

PMID: 16891448
DOI: 10.1158/1535-7163.MCT-06-C02

No abstract available

PubMed Disclaimer

Comment on

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.
Mayer LD, Harasym TO, Tardi PG, Harasym NL, Shew CR, Johnstone SA, Ramsay EC, Bally MB, Janoff AS. Mayer LD, et al. Mol Cancer Ther. 2006 Jul;5(7):1854-63. doi: 10.1158/1535-7163.MCT-06-0118. Mol Cancer Ther. 2006. PMID: 16891472

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems